<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02339779</url>
  </required_header>
  <id_info>
    <org_study_id>METC142059</org_study_id>
    <nct_id>NCT02339779</nct_id>
  </id_info>
  <brief_title>Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy</brief_title>
  <acronym>BREAST</acronym>
  <official_title>the Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicentre randomized controlled trial aims to evaluate a new breast reconstruction&#xD;
      technique- autologous fat transfer (AFT). Female patients with breast cancer schedule to&#xD;
      receive a mastectomy (or having undergone mastectomy in the past) will be randomized to&#xD;
      undergo breast reconstruction with either AFT (intervention group) or reconstruction with&#xD;
      implants (control group). AFT will be evaluated in terms of quality of life, aesthetic&#xD;
      result, complications, oncological safety and cost-effectiveness.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breast-related Quality of life (BREAST_Q)</measure>
    <time_frame>1 year</time_frame>
    <description>Measured by the BREAST-Q questionnaire (quality of life subdivision) preoperatively and 1 year postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aesthetic result</measure>
    <time_frame>1 year</time_frame>
    <description>The overall aesthetic result will be measured using 3D-photographs which will be assessed by a panel of independent plastisch surgeons, ex-breast cancer patients and healthy volunteers. In addition, the volume, shape and symmetry will be assessed by the patient using the BREAST-Q questionnaire (satisfaction with breasts subdivisions) at 1 year postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement of short-term als well as mid-term complications associated with procedures as well as (serious) adverse events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oncological safety</measure>
    <time_frame>5 years</time_frame>
    <description>Oncological follow-up will comply to the guidelines for breast cancer and will take place by a yearly consult with the oncological surgeon (including physical examination and mammography/ultrasound/MRI) for 5 years postoperatively. All (loco)regional and distant recurrences will be recorded and compared between both grops.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>1 year</time_frame>
    <description>Cost-effectiveness analysis to determine the intramural and socio-economic costs associated with the breast reconstruction treatment. It will be calculated according to the guidelines of the &quot;Instuction manual cost-effectiveness analysis&quot; (Handleiding kostenonderzoek) of the Dutch Health Institute (Zorginstituut Nederland).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">196</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Autologous fat transfer reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Breast reconstruction achieved by serial autologous fat transfer (AFT) procedures, accompanied by external tissue expansion of the breast.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reconstruction with breast implants</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group will receive implant-based reconstruction, in some cases preceded by the implantation of a tissue expander.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>autologous fat transfer</intervention_name>
    <description>Each procedure consists of the transfer of syringe-aspirated fat (form the abdomen, thighs, flanks) to the breast by injection in the subcutaneous planes.&#xD;
Typically three separate procedures are needed for a complete breast reconstruction:&#xD;
First session comprises of sub- and intrapectoral fat transfer during the primary mastectomy surgery, providing volume to the deep tissue planes.&#xD;
Second session is preceeded by wearing an external pre-expansion device to prepare the recipient site for grafting. It aims to give the breast its shape and initial volume.&#xD;
Third session is also preceded by external pre-expansion and aims to provide extra volume of the breast to achieve symmetry with the healthy breast.</description>
    <arm_group_label>Autologous fat transfer reconstruction</arm_group_label>
    <other_name>lipofilling</other_name>
    <other_name>fat grafting</other_name>
    <other_name>lipografting</other_name>
    <other_name>lipoaspirate grafting</other_name>
    <other_name>autologous fat injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>breast implant</intervention_name>
    <description>Implant-based reconstruction typically will occur as follows:&#xD;
During the primary mastectomy surgery, a tissue expander will be implanted subpectorally.&#xD;
The tissue expander will be gradually filled with sterile saline during outpatient clinic visits.&#xD;
When the desired volume is achieved, a second operation will be planned, to exchange the tissue expanded with the definite breast implant.&#xD;
(Note: in patients who are receiving encapsulectomy and implant exchange, the first 2 steps are skipped.)</description>
    <arm_group_label>Reconstruction with breast implants</arm_group_label>
    <other_name>breast prosthesis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female gender&#xD;
&#xD;
          -  Age of 18 years and older&#xD;
&#xD;
          -  History or in candidate for a mastectomy procedure in the near future&#xD;
&#xD;
          -  Patients' choice to undergo a breast reconstruction&#xD;
&#xD;
          -  Wanting to participate in this study&#xD;
&#xD;
          -  Patient is able to wear the BRAVA device&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active smoker or a history of smoking 4 weeks prior to surgery&#xD;
&#xD;
          -  Current substance abuse&#xD;
&#xD;
          -  History of lidocaine allergy&#xD;
&#xD;
          -  History of silicone allergy&#xD;
&#xD;
          -  4 weeks or less after chemotherapy&#xD;
&#xD;
          -  History of radiation therapy in the breast region&#xD;
&#xD;
          -  Oncological treatment includes radiotherapy after mastectomy&#xD;
&#xD;
          -  Kidney disease&#xD;
&#xD;
          -  Steroid dependent asthma (daily or weekly) or other diseases&#xD;
&#xD;
          -  Immune-suppressed or compromised disease&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  BMI&gt;30&#xD;
&#xD;
          -  Large breast size (i.e. larger than cup C), unless the patient prefers reduction of&#xD;
             the contralateral side towards Cup C&#xD;
&#xD;
          -  Extra-capsular silicone leaking from the encapsulated implant from a previous breast&#xD;
             reconstruction&#xD;
&#xD;
          -  The treating plastic surgeon has strong doubts on the patient's treatment compliance&#xD;
&#xD;
          -  Claustrophobia for an MRI-scan&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrzej Piatkowski de Grzymala</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Amstelland Hospital</name>
      <address>
        <city>Amstelveen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexander Monro Breast cancer hospital</name>
      <address>
        <city>Bilthoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amphia Hospital</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bronovo-MCH Hospital</name>
      <address>
        <city>Hague</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Groep Twente Hospital</name>
      <address>
        <city>Hengelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Centre (MUMC+)</name>
      <address>
        <city>Maastricht</city>
        <zip>6229HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 7, 2015</study_first_submitted>
  <study_first_submitted_qc>January 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2015</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fat grafting</keyword>
  <keyword>fat injection</keyword>
  <keyword>lipoaspirate</keyword>
  <keyword>fat transfer</keyword>
  <keyword>lipofilling</keyword>
  <keyword>liposculpturing</keyword>
  <keyword>lipoinjection</keyword>
  <keyword>lipotransfer</keyword>
  <keyword>breast reconstruction</keyword>
  <keyword>external pre-expansion</keyword>
  <keyword>BRAVA</keyword>
  <keyword>EVE</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

